MedTrace Logo

Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients

NCT03987217 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2025-05-14

No results posted yet for this study

Summary

This trial studies how well resistance training with or without creatine monohydrate supplement works in improving body composition and health outcomes in patients with prostate cancer that has spread to other places in the body. Resistance training, with or without creatine monohydrate supplement, may help to improve feelings of tiredness and overall physical function in patients with prostate cancer.

Conditions

  • Fatigue
  • Metastatic Prostate Carcinoma
  • Sedentary Lifestyle
  • Stage IV Prostate Cancer AJCC (American Joint Committee on Cancer) v8
  • Stage IVA Prostate Cancer AJCC (American Joint Committee on Cancer) v8
  • Stage IVB Prostate Cancer AJCC (American Joint Committee on Cancer) v8

Interventions

DIETARY_SUPPLEMENT

Creatine Monohydrate

Given orally

BEHAVIORAL

Exercise Intervention

Complete POWER resistance training program

OTHER

Questionnaire Administration

Ancillary studies

Sponsors & Collaborators

Principal Investigators

  • Adriana Coletta · Huntsman Cancer Institute/ University of Utah

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-17
Primary Completion
2025-03-10
Completion
2025-03-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03987217 on ClinicalTrials.gov